filmov
tv
'Psychedelics Refresh Thinking Processes' | Interview with DAVID NUTT, PhD
Показать описание
DAVID NUTT, PhD is Professor of Neuropsychopharmacology at the Imperial College London, UK.
Recorded at the Interdisciplinary Conference on Psychedelic Research David Nutt (ICPR) 2022, in Haarlem, The Netherlands.
GET YOUR ICPR 2024 TICKETS NOW!
Filmed by Drugreporter - Rights Reporter Foundation
Reporter: Péter Sárosi
Video: István Gábor Takács
Questions:
0:00 Intro
0:05 What will be the heritage of this psychedelic renaissance?
2:26 Can the pharmaceutical industry use psychedelics as modern medicines?
4:23 Can we separate the hallucinogenic effects of psychedelics from the medical benefits?
6:44 What's your view on microdosing?
7:59 How do psychedelics, such as psilocybin compare to traditional antidepressants in treating depression?
10:30 What about Ketamine? How does it compare to psilocybin, how does it affect the brain, and how does it treat depression?
13:05 Can these substances be used outside of their traditional contexts, as modern medicines?
14:52 How do you see the future of psychedelics? What role will they play in mainstream mental health care?
16:10 How can we overcome the scepticism of the general public and scientists, regarding psychedelics?
Recorded at the Interdisciplinary Conference on Psychedelic Research David Nutt (ICPR) 2022, in Haarlem, The Netherlands.
GET YOUR ICPR 2024 TICKETS NOW!
Filmed by Drugreporter - Rights Reporter Foundation
Reporter: Péter Sárosi
Video: István Gábor Takács
Questions:
0:00 Intro
0:05 What will be the heritage of this psychedelic renaissance?
2:26 Can the pharmaceutical industry use psychedelics as modern medicines?
4:23 Can we separate the hallucinogenic effects of psychedelics from the medical benefits?
6:44 What's your view on microdosing?
7:59 How do psychedelics, such as psilocybin compare to traditional antidepressants in treating depression?
10:30 What about Ketamine? How does it compare to psilocybin, how does it affect the brain, and how does it treat depression?
13:05 Can these substances be used outside of their traditional contexts, as modern medicines?
14:52 How do you see the future of psychedelics? What role will they play in mainstream mental health care?
16:10 How can we overcome the scepticism of the general public and scientists, regarding psychedelics?
Комментарии